Apigenin and Luteolin Attenuate the Breaching of MDA-MB231 Breast Cancer Spheroids Through the Lymph Endothelial Barrier in Vitro
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00220
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 14, 2018
Authors
Publisher
Frontiers Media SA